Ledger.Open graph →
SEC Form D · filed January 15, 2014

Promentis Pharmaceuticals, Inc

Offering
$2.9M
Sold
$820K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MILWAUKEE, WI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Klaus E. Veitinger, Md, Phd · Milwaukee, WIDirectorDavid E. Baker, Phd · Milwaukee, WIDirectorEd E. Barthell, Md · Mequon, WIDirectorDaniel E. Lawton · Milwaukee, WIDirectorPatrick E. Schwarz-Schuette · Dusseldorf, 2MDirectorVirinder E. Nohria, Phd · Milwaukee, WIDirectorDavid E. Wezdenko · New York, NYDirectorChad E. Beyer, Phd · Milwaukee, WIExec · DirectorRobert J. Klein · New York, NYDirectorGordon B. Mccormack · Carrabelle, FLDirectorJames C. Madden, V · San Francisco, CADirectorMarc F. Mcmorris · San Francisco, CADirectorChad E. Beyer, Phd · Milwaukee, WIExec · DirectorDaniel E. Lawton · Milwaukee, WIDirectorPatrick E. Schwarz-Schuette · Dusseldorf, 2MDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗